Literature DB >> 7001652

The interaction of [3H]miconazole with Candida albicans.

J E Cope.   

Abstract

During the stationary phase of a batch culture, Candida albicans develops the ability to take up large amounts of [3H]miconazole, and this occurs over the same period of time as the cells become resistant to miconazole-induced K+ release. Cell walls isolated from C. albicans also take up [3H]miconazole, and it is likely that the cell wall is the site of the association of [3H]miconazole with intact cells. Miconazole interaction with C. albicans is freely reversible and relatively nonspecific, and evidence suggests the involvement of hydrophobic bonding. Although fractionation studies were not exhaustive, results suggest that [3H]miconazole associates with glycoprotein and lipid in the matrix of the cell wall. Development of the ability to take up [3H]miconazole requires a low pH in the culture medium at the end of the growth phase, and efficient aeration, and was found to occur most rapidly in the presence of 0.3 mM sodium azide. The nature of the changes that occur during incubation through the stationary phase, and also similar changes that take place during cell wall preparation, and their relationship to phenotypic miconazole resistance are discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7001652

Source DB:  PubMed          Journal:  Sabouraudia        ISSN: 0036-2174


  4 in total

1.  Protonation of ketoconazole in relation to fungistatic activity.

Authors:  W H Beggs
Journal:  Mycopathologia       Date:  1991-10       Impact factor: 2.574

2.  Development of phenotypic resistance to direct lethal miconazole action by Candida albicans entering stationary phase.

Authors:  W H Beggs
Journal:  Mycopathologia       Date:  1989-12       Impact factor: 2.574

3.  Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans.

Authors:  W H Beggs
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

4.  Interaction between Candida agglutinins and antifungal agents.

Authors:  J C Lutz; K M Nugent
Journal:  Mycopathologia       Date:  1987-07       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.